Patent Assignment
Reel/Frame 013323/0956
Assignment of Assignor's Interest
Recorded: 2002-09-27
Pages: 3
Assignee
GENESENSE TECHNOLOGIES INC.
2 MERIDIAN ROAD, TORONTO, ONTARIO M9W 4Z7, CANADA
Covered Property
(1)
Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase
Patent:
6,121,000 →
Application:
09/249,730 →
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.